Xanthine phosphodiesterase v inhibitors
Details for Australian Patent Application No. 2001291022 (hide)
International Classifications
Event Publications
18 January 2007 Application Accepted
Published as AU-B-2001291022
17 May 2007 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2002
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser